Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

European approval for Roche’s next-gen breast cancer drug

European approval for Roche’s next-gen breast cancer drug Perjeta now available in EU for use before surgery in early stage aggressive breast cancer.  . ... We are committed to making the Perjeta regimen available to appropriate patients in the EU as early as possible.”.

UK pharma rebate payment doubles in one year

UK pharma rebate payment doubles in one year First quarter repayment £138m higher than this time last year

Roche maintains dominance as leading cancer drugmaker

Roche maintains dominance as leading cancer drugmaker drugs such as its next-generation breast cancer drug Perjeta (pertuzumab). ... This was highlighted in England where last year the country's health technology assessor NICE said Perjeta was nearly double the price (at £90, 000) than it would consider

Roche adds kidney cancer to anti-PD-L1 programme

Roche adds kidney cancer to anti-PD-L1 programme Sales of the company's HER2-targeting drugs - Herceptin (trastuzumab) and follow-up therapies Perjeta (pertuzumab) and Kadcyla (trastuzumab emtansine) - grew 23% thanks to increased use of Herceptin and Perjeta in ... The growth of Perjeta - up 82% to

England's Cancer Drugs Fund: Fixing a broken system

England's Cancer Drugs Fund: Fixing a broken system The Swiss firm has, in relative terms at least, not come out too badly during the de-listing process as two of its newer cancer medicines, namely breast cancer treatments Perjeta

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics